广西梧州中恒集团股份有限公司关于控股子公司为其全资子公司融资授信进行担保的公告

Core Viewpoint - The company, Guangxi Wuzhou Zhongheng Group Co., Ltd., has announced that its subsidiary, Chongqing Laimei Pharmaceutical Co., Ltd., will provide a guarantee for its wholly-owned subsidiary, Chongqing Laimei Longyu Pharmaceutical Co., Ltd., to secure a credit facility of RMB 10 million from Hengfeng Bank [2][3]. Group 1: Guarantee Details - The guarantee involves a credit facility of RMB 10 million with a loan term of one year, and there is no counter-guarantee involved [2]. - The company has approved a total credit limit of up to RMB 5 billion for 2025, with a maximum guarantee amount of RMB 2.5 billion [3]. - The guarantee is within the approved credit limit and does not require further board or shareholder approval [3]. Group 2: Subsidiary Information - Laimei Longyu is not listed as a dishonest executor [4]. - The guarantee is deemed necessary and reasonable due to Laimei Longyu's stable operating conditions, aligning with the company's long-term business development needs [7]. Group 3: Board Approval and Current Guarantees - The board meeting on March 27, 2025, approved the guarantee with unanimous support [7]. - As of the announcement date, the total external guarantee balance is RMB 373.49 million, which is 6.20% of the company's audited net assets for 2024, with no overdue guarantees reported [7].